The stock of Immatics N.V (IMTX) has gone up by 6.50% for the week, with a 0.75% rise in the past month and a -4.84% drop in the past quarter. The volatility ratio for the week is 5.20%, and the volatility levels for the past 30 days are 4.50% for IMTX. The simple moving average for the past 20 days is 3.94% for IMTX’s stock, with a -0.35% simple moving average for the past 200 days.
Is It Worth Investing in Immatics N.V (NASDAQ: IMTX) Right Now?
IMTX has 36-month beta value of 0.69. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IMTX is 71.66M, and currently, short sellers hold a 12.52% ratio of that float. The average trading volume of IMTX on May 02, 2024 was 423.80K shares.
IMTX) stock’s latest price update
Immatics N.V (NASDAQ: IMTX)’s stock price has soared by 8.86 in relation to previous closing price of 9.93. Nevertheless, the company has seen a gain of 6.50% in its stock price over the last five trading days. Seeking Alpha reported 2024-04-27 that Immatics, a German biotech company, achieved its Nasdaq listing in 2020 through a merger with Arya Sciences Acquisition Corp, a SPAC sponsored by Perceptive Advisors. The company focuses on developing T-cell receptor-based immunotherapies for solid tumors with unmet medical needs. Immatics has partnerships with Bristol Myers Squibb, Moderna, and Editas, and is advancing multiple candidates in clinical studies.
Analysts’ Opinion of IMTX
Mizuho, on the other hand, stated in their research note that they expect to see IMTX reach a price target of $12. The rating they have provided for IMTX stocks is “Buy” according to the report published on March 31st, 2023.
Bryan Garnier gave a rating of “Buy” to IMTX, setting the target price at $16 in the report published on March 24th of the previous year.
IMTX Trading at -4.20% from the 50-Day Moving Average
After a stumble in the market that brought IMTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.86% of loss for the given period.
Volatility was left at 4.50%, however, over the last 30 days, the volatility rate increased by 5.20%, as shares surge +2.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.93% lower at present.
During the last 5 trading sessions, IMTX rose by +6.50%, which changed the moving average for the period of 200-days by -4.42% in comparison to the 20-day moving average, which settled at $10.41. In addition, Immatics N.V saw 2.66% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IMTX
Current profitability levels for the company are sitting at:
- -1.88 for the present operating margin
- -1.2 for the gross margin
The net margin for Immatics N.V stands at -1.71. The total capital return value is set at -0.29.
Based on Immatics N.V (IMTX), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at 1.18. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -122.56.
Currently, EBITDA for the company is -80.65 million with net debt to EBITDA at 2.52. When we switch over and look at the enterprise to sales, we see a ratio of 15.48. The receivables turnover for the company is 9.41for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.87.
Conclusion
To put it simply, Immatics N.V (IMTX) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
